Jonathan E Freeman
CIK 1708133 · last filed 2026-02-06
Jonathan E Freeman is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for PHIO, was dated Feb 6, 2026. Current disclosed insider exposure totals $34.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$34.9K
3
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHIO | Director | 32,655 | $1.07 | $34.9K | $0 | 5 | 2026-02-06 |
| Phio Pharmaceuticals Corp. (PHIOW) Delisted | Director | 10,364 | $0.02 | $240 | $0 | 2 | 2021-03-03 |
| Phio Pharmaceuticals Corp. (RXIIW) Delisted | Director | 10,000 | — | — | $0 | 2 | 2018-08-03 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-06 | PHIO | Grant (A) | +16,600 | $0 | EDGAR |
| 2025-09-15 | PHIO | Grant (A) | +14,700 | $0 | EDGAR |
| 2024-09-13 | PHIO | Grant (A) | +1,000 | $0 | EDGAR |
| 2023-02-22 | PHIO | Grant (A) | +1,500 | $0 | EDGAR |
| 2022-02-16 | PHIO | Grant (A) | +10,000 | $0 | EDGAR |
| 2021-03-03 | Phio Pharmaceuticals Corp. (PHIOW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2019-02-15 | Phio Pharmaceuticals Corp. (PHIOW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2018-08-03 | Phio Pharmaceuticals Corp. (RXIIW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2017-06-07 | Phio Pharmaceuticals Corp. (RXIIW) Delisted | Grant (A) | — | $0 | EDGAR |